Why hormone testing matters in perimenopause
(and why “just HRT” can miss the point)
(and why “just HRT” can miss the point)
In perimenopause and menopause, it’s tempting to assume the answer is always HRT. And for many women, HRT can be life-changing. But there’s a big problem with the “HRT first, questions later” approach:
If you don’t test, you can end up treating the wrong driver — or using the right tool in the wrong way.
What I see again and again is that mood, cognition, sleep, energy, and resilience are not “just estrogen”. They are the output of a whole network: cortisol, thyroid hormones, oestrogen, progesterone, testosterone, insulin/metabolic health — all talking to each other, all capable of producing very similar symptoms.
So if we skip testing and assume “menopause = low oestrogen = HRT”, we risk staying stuck on a treatment that doesn’t fully fit the biology in front of us.
The talk highlights an integrative psychiatry lens: mental health symptoms often rise and fall with hormonal transitions — PMS, postpartum, perimenopause, menopause — and symptoms can worsen when there’s an additional inflammatory load (autoimmunity, infections like Lyme/tick-borne illness, metabolic dysfunction).
That matters because
This is where testing stops being optional and becomes the compass.
One of the most useful frameworks in the excerpt is the “trifecta” idea:
Thyroid, reproductive hormones, and cortisol often rise and fall together — and stress can knock the entire system off balance.
Cortisol isn’t just about stress. Chronically elevated or dysregulated cortisol can:
Clinically, this is huge: the woman who feels “wired but tired”, wakes at 3 a.m., feels anxious, depleted, and emotionally reactive may not primarily need “more oestrogen” — she may need her HPA axis mapped and supported.
Testing helps you see whether cortisol is high, low, flipped, or flat (and therefore what type of intervention is actually appropriate).
Thyroid function directly influences brain metabolism and neurotransmitter activity. Low thyroid activity can look like:
And importantly, thyroid dysfunction can be missed when women are told their TSH is “fine” even though they feel anything but fine.
A functional approach typically considers a full thyroid panel (not only TSH), because conversion issues, reverse T3, and antibodies can matter — especially under stress or inflammation.
If we don’t test properly, a woman can be labelled “depressed” (or “just menopausal”), when the bigger issue is thyroid-driven brain metabolism.
Yes, oestrogen fluctuations can strongly affect serotonin signalling, mood, and cognition — and many women notice the biggest emotional and cognitive shifts during perimenopause when hormones become erratic.
But the excerpt also reminds us:
So if you only focus on oestrogen (or only prescribe one formula), you may miss a progesterone deficit pattern, androgen depletion, or an inflammatory pattern that’s undermining the whole picture.
Here are the most common patterns I see when hormone therapy is started without deeper assessment:
HRT may soften hot flushes and sleep slightly, but mood, anxiety, brain fog, or motivation don’t fully return. Without testing, the next move is often: “increase the dose” or “try another patch”.
Sometimes that’s appropriate. Often, it’s not.
If cortisol is dysregulated, it can suppress thyroid and disrupt neurotransmitters. HRT may help a little, but the system is still running on stress chemistry.
If Hashimoto’s (or another autoimmune pattern) is present, symptoms can worsen around hormonal transitions. If you don’t check antibodies and a full panel, you can miss the root driver.
Insulin resistance and blood sugar instability can mimic (and worsen) perimenopausal symptoms: fatigue, poor sleep, irritability, anxiety, weight changes, cravings, low mood.
Sometimes symptoms aren’t from low hormones but from imbalance, poor clearance, inflammatory load, or incorrect ratios. In those cases, “more HRT” can worsen breast tenderness, headaches, mood swings, bloating, or irritability — and the woman loses confidence because she feels like her body is “failing” treatment.
Testing prevents this spiral.
Testing is not about chasing perfect numbers. It’s about matching the plan to the physiology you’re actually dealing with.
A robust approach often includes:
And crucially: testing is only useful when it changes what you do next.
When women feel emotionally “not themselves”, they deserve better than trial-and-error.
Testing allows you to answer questions like:
That’s how you avoid getting stuck — on HRT, on antidepressants, on “maybe it’s just stress” — while symptoms persist.
Perimenopause is a transition, not a diagnosis. And mood symptoms in this phase are not “all in your head”.
They’re often the predictable result of a shifting endocrine network interacting with stress load, immune function, thyroid physiology, and metabolic health.
HRT can be part of the solution — but testing is what makes it the right solution, for the right woman, at the right time, in the right way.
Call to Action:
If you are perimenopausal or menopausal and:
then it may be time to step back and get clarity.
In my clinic, we begin with a full clinical history and use targeted testing where appropriate to understand what is actually driving your symptoms. From there, we create a plan that supports hormones, thyroid function, stress physiology and metabolic health — together, not in isolation.
If you would like to explore this approach, you can book an initial consultation to discuss whether testing would be helpful for you at this stage.
You don’t need to guess your way through this transition.